p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials.
about
Alveolar macrophage innate response to Mycobacterium immunogenum, the etiological agent of hypersensitivity pneumonitis: role of JNK and p38 MAPK pathwaysPyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cellsIsoforms of p38MAPK gamma and delta contribute to differentiation of human AML cells induced by 1,25-dihydroxyvitamin D₃Serotonin facilitates long-term depression induction in prefrontal cortex via p38 MAPK/Rab5-mediated enhancement of AMPA receptor internalizationSmall-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonistsPost-transcriptional regulation of pro-inflammatory gene expression.Inhibitors of mitogen-activated protein kinases downregulate COX-2 expression in human chondrocytesNoise propagation in two-step series MAPK cascadeThe rational design of specific peptide inhibitor against p38α MAPK at allosteric-site: a therapeutic modality for HNSCCp38 MAPK signaling in postnatal tendon growth and remodelingMultiple Protein Kinases via Activation of Transcription Factors NF-κB, AP-1 and C/EBP-δ Regulate the IL-6/IL-8 Production by HIV-1 Vpr in AstrocytesArf6-GEF BRAG1 regulates JNK-mediated synaptic removal of GluA1-containing AMPA receptors: a new mechanism for nonsyndromic X-linked mental disorder.A bacterial cytotoxin identifies the RhoA exchange factor Net1 as a key effector in the response to DNA damageP38 MAP kinase signaling is required for the conversion of CD4+CD25- T cells into iTreg.Rapid activation of G2/M checkpoint after hypertonic stress in renal inner medullary epithelial (IME) cells is protective and requires p38 kinase.p38 MAPK regulates IL-1beta induced IL-6 expression through mRNA stability in osteoblastsNovel therapy for COPD.Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release.p38gamma mitogen-activated protein kinase suppresses chondrocyte production of MMP-13 in response to catabolic stimulationTelekin suppresses human hepatocellular carcinoma cells in vitro by inducing G2/M phase arrest via the p38 MAPK signaling pathway.Using the one-lung method to link p38 to pro-inflammatory gene expression during overventilation in C57BL/6 and BALB/c miceTube formation in the first trimester placental trophoblast cells: Differential effects of angiogenic growth factors and fatty acids.Therapy of systemic lupus erythematosus: a look into the futureMolecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes.TRPV1 potentiates TGFβ-induction of corneal myofibroblast development through an oxidative stress-mediated p38-SMAD2 signaling loop.Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease.The anti-inflammatory carbazole, LCY-2-CHO, inhibits lipopolysaccharide-induced inflammatory mediator expression through inhibition of the p38 mitogen-activated protein kinase signaling pathway in macrophages.Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.Therapeutic modulation of signal transduction pathways.Role of apoptotic signaling pathways in regulation of inflammatory responses to ricin in primary murine macrophagesActivated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatics.p38 MAP kinase modulates liver cell volume through inhibition of membrane Na+ permeability.Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase: Regulators of distinct cell death and survival pathways in granulocytes.Signaling molecules in sulfur mustard-induced cutaneous injuryMitogen-activated protein kinase p38 in HIV infection and associated brain injury.The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNA-methylating agentsFuture therapeutic treatment of COPD: struggle between oxidants and cytokinesSilencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signalingThe inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cellsHuman immunodeficiency virus type 1 viral protein R (Vpr) induces CCL5 expression in astrocytes via PI3K and MAPK signaling pathways.
P2860
Q23913437-04797648-8402-4938-B3E4-0243C07307D3Q24562099-8BEDC714-947A-4F7F-8C95-1DCC29A6B75CQ24569633-D197DCE5-18EF-42AB-9B72-D4398C7DF706Q24653961-A26EED7E-1819-4AD5-8D06-1434FD479795Q24794838-3EA689AF-C8C5-4BC2-9DC3-38301E6C2582Q24806889-EBA0BABD-208A-4FF9-863B-6EF4F82E2115Q24815106-BA4EA659-9C23-4DB3-B920-A7D041B842D7Q28483138-D4541FF2-E20E-4FBE-91C0-CC18F2FDF210Q28540228-CAC796F9-C0C2-4F2A-A7E7-81007DE3A9F8Q28544034-8D7C111F-88F3-427D-A4DE-7D10C82E6E42Q28547228-102B8EFA-D31B-49E1-BA29-8B24A0F5CA60Q30422340-657616B3-5227-482C-B15E-CFBA7DE4CC6FQ33338459-94359D17-41DC-40E4-A51A-FECF4311B310Q33373059-2C34780E-AB67-41E1-A7BB-2BE30DAD165DQ33897027-B382EDBD-FD07-45F9-8207-487217753ADAQ33947764-92BD2734-1239-44CC-97DC-2563431B7246Q34074654-8364EB51-70EC-4792-A2BE-0404FA851284Q34086292-B53919E9-A797-4D8B-9573-3552B4D10F34Q34088405-C6497FC5-7064-41CD-9507-CEF6E169771FQ34295048-65077E4C-8F58-4E41-95F5-0C45CC09E2D0Q34358492-8B5EED38-DFB5-4C64-8F63-FF43A3DC68C2Q34518890-D033BD4A-1138-47F8-B840-3A56352109CEQ34731092-0C12D1E7-4FCB-4C72-8862-4B69594795E5Q34998247-185A081B-6AED-4CC2-90FB-E6ED32E1A3E9Q35009747-33D92A70-E213-46F4-97CF-B5BA9D18988CQ35010587-D0406ABA-B981-4D55-A6E4-9BB6C303F8B7Q35046269-67DBA0E9-7B02-46BC-8C57-894C5C43C887Q35607297-70964CA6-D7FF-4815-B8C9-ABB680C68FEDQ35787657-33DE5AC9-FCDF-45C7-AC65-BC99E17CF674Q35819321-DE567F90-0BFE-4875-9118-7161E0703481Q35827427-08F0A9B3-4D0F-4720-BA56-AA54579BDB5BQ36168881-4263EA87-8D19-4BFB-BE9B-D1946D27E051Q36368794-D770032F-E477-4A18-AFE9-7DE3227C32C7Q36391596-98DE69CA-0ED0-466E-9BA9-CDA17D4BBEF6Q36950000-53EFF28B-ED3D-4E18-8C73-7751F51F394FQ37056618-FDAA4D09-64BA-4341-9DAD-D39784B25E2FQ37071004-7D38BEAE-2393-4E97-BE85-368D8158FEFEQ37176427-73DA83E7-F1F1-4504-BAC1-884F1E2FD944Q37288834-433E3E76-9EEE-4788-98D7-9F0A1E778276Q37319262-9CBA4DE2-5CBC-4E11-AD70-14664822C61F
P2860
p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials.
@ast
p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials.
@en
type
label
p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials.
@ast
p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials.
@en
prefLabel
p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials.
@ast
p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials.
@en
P2093
P1476
p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials.
@en
P2093
P304
P356
10.1016/S0163-7258(99)00008-X
P577
1999-05-01T00:00:00Z